Blood Sugar Lancets Market (Updated Version Available)

The Blood Sugar Lancets market was valued at xxx million USD with a CAGR xx% from 2015-2019. Subsequently, it will touch xxx million USD in 2020 with a CAGR xx % from 2020 to 2025.
A blood sugar lancet is a small medical device used in capillary blood sampling. It looks similar to a scalpel but has a double-edged needle or blade. Blood sugar lancets are used to make minuscule punctures to obtain blood samples and are mostly disposable. The blood sugar lancet market is a part of the global diabetes market as they are commonly used to measure blood glucose levels. The depth of the skin to be penetrated can be adjusted for various levels of skin thickness. Some devices can even be used to measure the acid base status of an unborn foetus.
As per the International Diabetes Federation, it is estimated that nearly 642 million people will suffer from diabetes by the year 2040. This amounts to nearly 1 in 10 adults. They are anticipated to be the biggest driver of the blood sugar lancet market in the coming decade. Diabetes is far more likely to occur in obese or senior citizens in any country. Western countries are already troubled by both these health predicaments. There is also an increasing number of both type 1 and type 2 cases of diabetes being reported in children and thus, governments will be under increasing pressure to tackle the issue head one. The blood sugar lancet market will allow people to monitor their glucose level, keep it under control and take the medication as and when required. 
The second driver of the blood sugar lancet market is the reimbursement options available, especially in developed countries. These devices are typically replaced every six to eight months which makes them expensive in the long run. Thus, patients prefer health insurance plans that cover most of the device expenditure. These plans also provide coverage for glucose test strips, glucose meters and diabetes testing supplies. In the U.S. alone, Medicare covers almost 80% of the cost of blood glucose monitoring devices like blood sugar lancets. The American Association of Diabetes Educators has also published a reimbursement procedure for primary caregivers, which categorically states that Medicare will reimburse medical service costs of diabetic patients.
In the global Blood Sugar Lancets market, This report focuses particularly in North America, South America, Europe and Asia-Pacific, and Middle East and Africa. This report classifies the market on the basis of application, type, regions, and manufactures.

In global market, the following companies are covered:
Bayer
Roche
AgaMatrix
Nova Biomedical
Integrity Applications
Medisana


Market Segment by Product Type
Disposable
Non-Disposable

Market Segment by Application
Hospitals
Clinics
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Blood Sugar Lancets market for the forecast period 2020 - 2025?
• What are the driving forces in the Blood Sugar Lancets market for the forecast period 2020 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Blood Sugar Lancets industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?